Robert Berman, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 18,360 shares at $26.21 ($481K) on 2017-11-09, disclosed to the SEC on 2017-11-14.
Open-market sale of $481k BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.21 | 3,672 | $96K | 20.0% |
| 2 | $26.21 | 14,688 | $385K | 80.0% |
| Total | $26.21 avg | 18,360 | $481K | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $6.6M | — | Filing → |